Value of Endorectal Ultrasound in Preoperative Prediction of Circumferential Resection Margin of Rectal Cancer
-
摘要:
目的 评估直肠腔内超声(endorectal ultrasound, ERUS)诊断直肠癌环周切缘(circumferential resection margin, CRM)的可行性和准确性 目的 回顾性分析2010年5月至2013年12月在北京协和医院行术前ERUS评估的直肠癌患者120例。纳入患者仅采用直肠全系膜切除术切除肿瘤, 未采用术前新辅助放化疗治疗。患者行术前ERUS检查时测量CRM, 即肿瘤的最外缘与直肠系膜筋膜的最短距离。以病理结果为金标准, 比较不同CRM诊断标准下ERUS的诊断价值。分析ERUS对不同位置、距肛缘距离、分期的CRM诊断准确性差异 结果 ERUS可以显示直肠系膜筋膜114例, 显示率为95%。采用不同探头频率, 直肠系膜筋膜显示的差异存在统计学意义(P=0.034)。以CRM ≤ 2 mm为标准时, ERUS诊断CRM的敏感性、准确性、阴性预测值最高, 分别为100%、98.2%、100%。ERUS对不同位置、距肛缘距离、病理分期病灶的诊断准确性差异不具有统计学意义(P>0.05) 结论 ERUS可以准确诊断直肠癌环周切缘, 同时具有较高的阴性预测值, 可为判断预后及制定临床治疗方案提供可靠依据。 Abstract:Objective To evaluate the feasibility and accuracy of endorectal ultrasound (ERUS) in predicting the circumferential resection margin (CRM) of rectal cancer. Methods Between May 2010 and December 2013, 120 patients with rectal cancer preoperatively evaluated with ERUS in Peking Union Medical College Hospital were retrospectively analyzed. The patients underwent total mesorectal excision without neoadjuvant chemoradiotherapy. CRM was measured with preoperative ERUS, i.e. the shortest distance between the outer edge of tumor and the mesorectal fascia. With pathological results as gold standard, the diagnostic values of ERUS under different criteria for CRM were assessed. The diagnostic accuracies of ERUS in predicting CRM among different positions, distances from the anal verge, and stages were analyzed. Results ERUS showed mesorectal fascia in 114 cases (95%). The display rates of mesorectal fascia by ERUS with different transducer frequencies were significantly different (P=0.034). With CRM ≤ 2 mm as the standard, the sensitivity, accuracy and negative predictive value of ERUS in predicting CRM were the highest (100%, 98.2%, 100%). The diagnostic accuracies of ERUS among different positions, distances from the anal verge, and stages were not significantly different (P>0.05). Conclusion ERUS can accurately predict CRM, with a high negative predictive value, which can provide reliable information for assessment of prognosis and formulation of clinical treatment plan. -
表 1 120例直肠癌病灶的基本情况
项目 例(%) 位置 前 24(20.0) 后 31(25.8) 左 27(22.5) 右 36(30.0) 环肠一周 2(1.7) 病灶距肛缘距离 下段(≤6 cm) 44(36.7) 中段(7~10 cm) 76(63.3) pT和pN分期 pT1 12(10.0) pT2 44(36.7) pT3 63(52.5) pT4 1(0.8) pN0 72(60.0) pN1 43(35.8) pN2 5(4.2) 病理CRM 阴性 114(95.0) 阳性 6(5.0) CRM:直肠癌环周切缘 表 2 影响MRF显示的因素比较
因素 MRF可显示
(n=114)MRF未显示
(n=6)χ2值 P值 探头频率 4.511 0.034 5~7 MHz 50 0 9~10 MHz 64 6 扩张肠腔 0.067 0.796 肠腔注水 44 2 探头水囊 70 4 MRF:直肠系膜筋膜 表 3 不同CRM诊断标准下ERUS的诊断价值
CRM诊断标准 敏感性 特异性 准确性 阳性预测值 阴性预测值 ≤1 mm 50 100 97.3 100 97.2 ≤2 mm 100 98.1 98.2 75 100 ≤3 mm 100 96.2 96.4 60 100 CRM:同表 1;ERUS:直肠腔内超声 表 4 不同位置、距肛缘距离、分期的CRM诊断准确性比较
因素 CRM可显示
(n=112)CRM未显示
(n=2)P值 距肛缘距离 0.067 下段(≤6 cm) 41 2 中段(7~10 cm) 71 0 位置* 0.058 右 33 1 左 25 1 前 22 0 后 30 0 pT分期 0.940 pT1+pT2 53 1 pT3+pT4 59 1 pN分期 0.759 N0 68 1 N1+N2 44 1 CRM:同表 1;*2例环肠一周的病例被排除 -
[1] Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer?[J]. J Clin Oncol, 2008, 26:303-312. doi: 10.1200/JCO.2007.12.7027 [2] Baik SH, Kim NK, Lee YC, et al. Prognostic significance of circumferential resection margin following total mesorectal excision and adjuvant chemoradiotherapy in patients with rectal cancer[J]. Ann Surg Oncol, 2007, 14:462-469. doi: 10.1245/s10434-006-9171-0 [3] Wibe A, Rendedal PR, Svensson E, et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer[J]. Br J Surg, 2002, 89:327-334. doi: 10.1046/j.0007-1323.2001.02024.x [4] Peeters KC, Marijnen CA, Nagtegaal ID, et al. The TME trial after a median follow-up of 6 years:increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma[J]. Ann Surg, 2007, 246:693-701. doi: 10.1097/01.sla.0000257358.56863.ce [5] Quirke P, Durdey P, Dixon MF, et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision[J]. Lancet, 1986, 2:996-999. http://www.ncbi.nlm.nih.gov/pubmed/2430152 [6] Frasson M, Garcia-Granero E, Roda D, et al. Preoperative chemoradiation may not always be needed for patients with T3 and T2N+ rectal cancer[J]. Cancer, 2011, 117:3118-3125. doi: 10.1002/cncr.25866 [7] Burton S, Brown G, Daniels IR, et al. MRI directed multidisciplinary team preoperative treatment strategy:the way to eliminate positive circumferential margins?[J]. Br J Cancer, 2006, 94:351-357. doi: 10.1038/sj.bjc.6602947 [8] MERCURY Study Group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer:Results of the MERCURY study[J]. Radiology, 2007, 243:132-139. doi: 10.1148/radiol.2431051825 [9] MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer:Prospective observational study[J]. BMJ, 2006, 333:779. doi: 10.1136/bmj.38937.646400.55 [10] Al-Sukhni E, Milot L, Fruitman M, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer:a systematic review and meta-analysis[J]. Ann Surg Oncol, 2012, 19:2212-2223. doi: 10.1245/s10434-011-2210-5 [11] Xie H, Zhou X, Zhuo Z, et al. Effectiveness of MRI for the assessment of mesorectal fascia involvement in patients with rectal cancer:a systematic review and meta-analysis[J]. Dig Surg, 2014, 31:123-134. doi: 10.1159/000363075 [12] Phang PT, Gollub MJ, Loh BD. et al. Accuracy of endorectal ultrasound for measurement of the closest predicted radial mesorectal margin for rectal cancer[J]. Dis Colon Rectum, 2012, 55:59-64. doi: 10.1097/DCR.0b013e318235b885 [13] Granero-Castro P, Muñoz E, Frasson M, et al. Evaluation of mesorectal fascia in mid and low anterior rectal cancer using endorectal ultrasound is feasible and reliable:a comparison with MRI findings[J]. Dis Colon Rectum, 2014, 57:709-714. doi: 10.1097/DCR.0000000000000096 [14] Frasson M, Garcia-Granero E, Roda D, et al. Preoperative chemoradiation may not always be needed for patients with T3 and T2N+ rectal cancer[J]. Cancer, 2011, 117:3118-3125. doi: 10.1002/cncr.25866 [15] Purkayastha S, Tekkis PP, Athanasiou T, et al. Diagnostic precision of magnetic resonance imaging for preoperative prediction of the circumferential margin involvement in patients with rectal cancer[J]. Colorectal Dis, 2007, 9:402-411. doi: 10.1111/j.1463-1318.2006.01104.x [16] Beets-Tan RG, Beets GL, Vliegen RF, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery[J]. Lancet, 2001, 357:497-504. doi: 10.1016/S0140-6736(00)04040-X [17] Peschaud F, Cuenod CA, Benoist S, et al. Accuracy of magnetic resonance imaging in rectal cancer depends on location of the tumor[J]. Dis Colon Rectum, 2005, 48:1603-1609. doi: 10.1007/s10350-005-0051-7